Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Binder

Showing results (171-180 of 219) with videos related to

Pageof 22
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 22, 2011
Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2A Assinger, M Laky, G Schabbauer, et al.
Thrombosis and Haemostasis|December 22, 1988
Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarctionK Huber, D Rosc, I Resch, et al.
The Journal of Biological Chemistry|May 16, 2000
Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1R Hofer-Warbinek, J A Schmid, C Stehlik, et al.
Thrombosis and Haemostasis|March 1, 2000
Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery diseaseM Nikfardjam, S Graf, R Beckmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2001
Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cellsD Mechtcheriakova, G Schabbauer, M Lucerna, et al.
The Journal of Biological Chemistry|May 15, 1989
Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activatorJ Wojta, R Beckmann, L Turcu, et al.
Thrombosis and Haemostasis|June 3, 1998
The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolismM Stegnar, P Uhrin, P Peternel, et al.
The Journal of Investigative Dermatology|July 27, 1999
Protein C inhibitor is expressed in keratinocytes of human skinM Krebs, P Uhrin, A Vales, et al.
International Archives of Allergy and Immunology|January 16, 1998
What have mast cells to do with edema formation, the consecutive repair and fibrinolysis?P Valent, C Sillaber, M Baghestanian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1997
Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivoG Christ, P Hufnagl, C Kaun, et al.
Pageof 22

Showing results (171-180 of 219) with videos related to

Sort By:
Pageof 22
Journal of Thrombosis and Haemostasis : JTH|January 22, 2011
Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2A Assinger, M Laky, G Schabbauer, et al.
Thrombosis and Haemostasis|December 22, 1988
Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarctionK Huber, D Rosc, I Resch, et al.
The Journal of Biological Chemistry|May 16, 2000
Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1R Hofer-Warbinek, J A Schmid, C Stehlik, et al.
Thrombosis and Haemostasis|March 1, 2000
Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery diseaseM Nikfardjam, S Graf, R Beckmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2001
Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cellsD Mechtcheriakova, G Schabbauer, M Lucerna, et al.
The Journal of Biological Chemistry|May 15, 1989
Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activatorJ Wojta, R Beckmann, L Turcu, et al.
Thrombosis and Haemostasis|June 3, 1998
The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolismM Stegnar, P Uhrin, P Peternel, et al.
The Journal of Investigative Dermatology|July 27, 1999
Protein C inhibitor is expressed in keratinocytes of human skinM Krebs, P Uhrin, A Vales, et al.
International Archives of Allergy and Immunology|January 16, 1998
What have mast cells to do with edema formation, the consecutive repair and fibrinolysis?P Valent, C Sillaber, M Baghestanian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1997
Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivoG Christ, P Hufnagl, C Kaun, et al.
Pageof 22